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■ Abstract
Background and Objective: Interleukin (IL) 4 is a cytokine that mediates allergic responses. Different single nucleotide polymorphisms (SNPs) 
can inﬂ uence the immune response mediated by cytokines. The aim of the present study was to investigate the possible association 
between IL-4 polymorphisms and allergic rhinitis and atopic asthma. 
Methods: A total of 214 atopic patients (108 with asthma and 106 with allergic rhinitis) and 120 healthy controls from Pakistan 
were genotyped for IL-4 SNPs C-589T (rs2243250), T+2979G (rs2227284), and C-33T (rs2070874) using restriction fragment length 
polymorphism-polymerase chain reaction. Statistical analysis was performed using the statistical software package StatCalc, EpiInfo v.6. 
Results: The SNP rs2243250 was signiﬁ cantly associated with both asthma (P=.004, Ƶ2=11.0) and allergic rhinitis (P<.001, Ƶ2=20.2), as 
was T-2979G (P<.001, Ƶ2=22.51 for asthma and P<.001, Ƶ2=57.6 for allergic rhinitis). The most frequent genotypes in the asthma and 
allergic rhinitis groups were TT for SNP rs2243250, and GG for SNP rs2227284. rs2070874 was not found to be associated with either 
of the 2 atopic respiratory diseases analyzed in the Pakistani cohort.
Conclusions: rs2243250 and rs2227284 are signiﬁ cantly associated with asthma and allergic rhinitis. The results of this study indicate that 
in addition to environmental factors, genetic risk factors also play an important role in the development of atopic respiratory diseases. 
Key words: IL-4. Polymorphism. Disease-associated. Atopic asthma. Allergic rhinitis.
■ Resumen
Introducción y objetivo: La IL-4 es una citocina que media las reacciones alérgicas. Diferentes polimorﬁ smos en nucleótidos simples (SNPs) 
pueden inﬂ uir sobre la respuesta mediada por citocinas. El motivo de este trabajo fue investigar la posible asociación de polimorﬁ smos 
de la IL-4 con rinitis alérgica (RA) o asma atópica.
Método: Se incluyó un total de 214 pacientes atópicos (asma n=108, RA n=106) y 120 controles sanos de Paquistán que fueron genotipados 
para SNPs IL-4 C-589T (rs2243250), T+2979G (rs2227284) y C-33T (rs2070874) mediante PCR. El análisis estadístico se llevó a cabo 
mediante el paquete StatCalc, EpiInfo v.6. 
Resultados: Observamos que el SNPs rs2243250 se asocia de forma signiﬁ cativa a asma (p 0.004; Ƶ2=11.0) y a RA (p<0.001; Ƶ2=20.2). 
Los genotipos más frecuentes en asma y RA fueron TT para SNP rs2243250, y GG para SNP rs2227284. Por otra parte, el SNP rs2070874 
no se asocia con ninguna enfermedad respiratoria en una cohorte pakistaní. 
Conclusiones: rs2243250 y rs2227284 se asocian signiﬁ cativamente a asma y a RA. Los resultados de este estudio demuestran que además 
de los factores ambientales, los factores genéticos de riesgo juegan un papel importante en el desarrollo de las enfermedades atópicas 
respiratorias.
Palabras clave: IL-4. Polimorﬁ smo. Enfermedad-asociada. Asma atópica. Rinitis alérgica.
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Introduction
Cross-talk between genetic and epigenetic variations is 
crucial for disease manifestation and progression. Genetic 
variations, such as single nucleotide polymorphisms (SNPs), 
in different genes involved in complex inÁ ammatory disorders, 
such as asthma, allergic rhinitis, and eczema have gained much 
attention. The cytokine-gene cluster located on chromosome 5 
harbors the interleukin (IL) genes IL-13, IL-4, IL-5, IL-3, and 
the granulocyte-macrophage colony-stimulating factor gene 
GM-CSF, which all have an important role in atopic disease 
susceptibility [1-3]. 
Both IL-4 and IL-13 are key components of the immune 
system and are involved in functions such as immunoglobulin 
class switching in activated B lymphocytes, inhibition of 
the production of proinÁ ammatory cytokines by monocytes, 
and increased endothelial cell surface expression of vascular 
cell adhesion molecule 1 [4]. IL-4 mediates these responses 
by binding to the T-cell surface through a heterodimeric 
receptor called the IL-4 receptor alpha chain (IL-4R_). The 
gene that codes for IL-4R_ is located in the chromosome 16p 
region, which has been linked to atopy and increased serum 
immunoglobulin (Ig) E levels [5,6].
Increased serum IgE levels are indicative of allergic 
response and correspond to a high level of IL-4 messenger RNA 
(mRNA) synthesis. It has been suggested that enhanced IL-4 
transcription is derived from genetic variations in the promoter 
region. In this regard, a promoter polymorphism (rs2243250; 
C-589T) has been reported to be associated with asthma and 
atopic dermatitis [7,8]. Along with promoter polymorphisms, 
various other SNPs have also been found to be associated 
with atopic disease in various populations. An association 
for T2979G and C-33T, also referred to as 3017 and +33, 
for example, has been reported in white asthmatic patients 
in Baltimore and German populations, respectively [9,10]. 
Replication of these association studies in other ethnic 
groups, however, has yielded controversial results. The aim 
of the present study was to determine the role of IL-4 SNPs 
in patients with asthma and allergic rhinitis in a Pakistani 
cohort.
Study Participants and Methods
Study Participants
The current case-control study included 120 controls 
and 214 atopic patients (108 with atopic asthma and 106 
with allergic rhinitis). All the patients were recruited from 
the Allergy Centre of the National Institute of Health in 
Islamabad, Pakistan. Inclusion criteria for controls were the 
absence of allergic reactions, negative skin prick tests, and 
total serum immunoglobulin (Ig) E levels of less than 100 IU/mL. 
Patients were diagnosed with atopic asthma according to the 
following criteria: a positive skin prick test reaction to at least 
1 aeroallergen (pollen) and a history of shortness of breath 
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Table 1. List of Primers Used for Genotyping
  Primers Primer Sequence ºCa PCR Product
rs2243250_F TAAACTTGGGAGAACATGGT 50 195 bp
rs2243250_R TGGGGAAAGATAGAGTAATA
  
rs2227284_ F CTACTCTTGGCAGTTGCTGGAA 58 220 bp
rs2227284_R GGAACTCTCTGTAGAATTATGAACTTTAGGTC
  
rs2070874_ F CAAGTTACTGACAATCTGGTGT 58 223 bp
rs2070874_R CGGCACATGCTAGCAGGAA  
Abbreviations: bp, base pairs; PCR, polymerase chain reaction.
aºC, annealing temperature.
Table 2. Genomic Sequence Polymorphism Analysis of IL-4 Gene by RFLP
  rs Number cDNA Coordinates Position Enzyme RE RFLP Fragments
  of SNPs  Units 
 
rs2243250 c.-589 C>T Promoter 2.5 AvaII C=177,18, T= 195
rs2227284 c.183+2527T>G Intron 2 2.5 AluI T=122,53,45,   
     G=122,98
rs2070874 c.-33C>T 5v UTR 5 BsmAI C= 178,45, 
     T= 140,45,38
Abbreviations: cDNA, complementary DNA; IL-4, interleukin 4; RE, restriction enzyme; RFLP, restriction fragment length polymorphism. 
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and wheezing due to chest tightness. Allergic rhinitis was 
diagnosed in patients with the following symptoms: sneezing, 
runny nose, nasal obstruction, itchy nose, and rhinorrhea. 
Genotyping of SNPs 
Genomic DNA was extracted using the standard phenol 
chloroform method. Genotyping was performed for the 
detection of 3 IL-4 SNPs using restriction fragment length 
polymorphism-polymerase chain reaction (RFLP-PCR).
PCR was performed using the Thermo Electron 
Corporation PCR system (PXE 0.2 Thermal cycler) and the 
Applied Biosystem Gene Amp PCR System 2700. The primer 
pairs used for the 3 SNPs are shown in Table 1. The PCR 
reaction contained 1X Taq Buffer (10 mM Tris-HCl, pH 9.0, 
50m M KCl, 0.1% Triton X-100, 0.01% gelatin) (Fermentas), 
10 pmol of each primer, 1.5 mM MgCl2, 0.2 mM dNTP, 1U 
of Taq DNA polymerase (Fermentas), and 100 ng of genomic 
DNA. The thermocycler profile consisted of 35 cycles. 
Before the À rst cycle, a 5-minute initial denaturation cycle 
was carried out at 95°C. Each cycle consisted of denaturation 
at 95ºC for 45 seconds followed by primer annealing for 45 
seconds at 50°C for the -589(C/T) SNP and at 58°C for other 
2 SNPs, with primer extension at 72°C for 45 seconds. Finally 
the temperature was held at 72°C for 7 minutes to allow the 
synthesis of unextended strands.
Restriction enzyme digestion for the PCR products of 
IL-4 C-589T, T2979G, and C-33T was carried out by adding 
2 +L 10X Buffer R (10 mM Tris-HCl [pH 8.5 at 37°C], 10 mM 
MgCl2, 100 mM KCl, and 0.1 mg/mL bovine serum albumin) 
and the respective restriction enzyme (Table 2) to a PCR 
tube containing 15 +L of PCR product and 5 +L of DNAase 
and RNAase free water. The mixture was spinned down and 
incubated at 37°C for 16 hours. The enzyme was deactivated 
at 65°C for 15 minutes. 
Statistical Analysis
Statistical differences for genotype and allele frequencies 
between patients and controls were determined by computing 
the Pearson r2 and odds ratios (ORs), with 95% CIs, using 
the statistical software package StatCalc EpiInfo v.6. 
Results
Three IL-4 SNPs, C-589T (rs2243250), T 2979G 
(rs2227284), and C-33T (rs2070874), were genotyped in 
healthy controls and patients with atopic asthma and allergic 
rhinitis. 
Genotyping Analysis
The C-589T SNP was found to be signiÀ cantly associated 
with both asthma (P=.004,  r2=11.0) and allergic rhinitis 
(P<.001,  r2=20.2) compared with controls. Of the 3 allelic 
combinations, the TT genotype was signiÀ cantly associated 
with asthma and allergic rhinitis, with P values of <.001 
(r2=10.88) and <.001 (r2=19.72), respectively. 
Similarly, a highly signiÀ cant association was observed for 
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the T2979G SNP in both asthma and allergic rhinitis patients, 
with P values of <.001 (r2=22.51) and <.001 (r2=57.66), 
respectively. The TT genotype might play a protective role as 
53.3% of controls had this genotype, compared with 25% of 
patients with asthma (P<.001;  r2=19.03; OR, 3.43 [95% CI, 
1.88-6.28]) and 16% of those with allergic rhinitis (P<.001; 
r2=34.05; OR, 5.98 [95% CI, 3.05-11.84). The GG genotype, 
in contrast, was signiÀ cantly associated with disease, as it was 
detected in 29.3% of allergic rhinitis patients but in none of 
the controls.
For the third polymorphism, C-33T, no significant 
difference was observed between patients and controls in terms 
of genotype or allele frequencies (Tables 3 and 4).
A signiÀ cant difference in allele frequencies was observed 
for C-589T in patients with allergic rhinitis (P<.001;  r2=9.67; 
OR, 1.81 [95% CI, 1.22-2.67]) but not in those with asthma 
(P<.10;  r2=2.68; OR, 1.36 [95% CI, 0.92-2.01]) compared 
with controls. Similarly for T2979G, allele frequencies 
differed signiÀ cantly between controls and patients with 
asthma (P<.001; r2=15.45; OR, 2.21 [95% CI, 1.46-3.37]) 
and allergic rhinitis (P<.001;  r2=54.41; OR, 4.29 [95% CI, 
2.81-6.56]) (Table 4).
Discussion
Asthma and other atopic diseases are considered to be 
multifactorial, with immunological, environmental, and 
genetic factors all contributing towards disease manifestation 
and progression. In recent genome-wide association studies, 
it has been proposed that genetic variations in the genes of 
the immunological pathways such as IL-4/IL-13 might be 
associated with disease phenotype. However, contradictory 
reports exist regarding the association of C-589T with allergy 
susceptibility. In asthma patients in the United Kingdom [11], 
Kuwait [12], China [13], Brazil [14], and India [15,16], for 
instance, no signiÀ cant associations were observed for this 
SNP. In the current study, a highly signiÀ cant association 
was observed between C-589T and both atopic asthma and 
allergic rhinitis. Our results are consistent with those reported 
by studies of asthmatic patients in Japan [17], Germany [18], 
and Taiwan [19].
In German asthmatic patients, a signiÀ cant association was 
observed for the C-33T SNP; 2979G, in contrast, reached only 
borderline signiÀ cance [10]. These À ndings are not consistent 
with ours, as we detected no association for C-33T but did 
À nd a strong association for T2979G. In the German study, 
T2979G was denoted G2979T. We used the dbSNP database 
notation T2979G. The authors of another study reported that 
T2979G (also referred to as 3017G/T) might be involved in 
transcriptional regulation of IL-4 as it is located in the putative 
transcription factor binding site for the peroxisome proliferator-
activated receptor alpha (PPARƠ). The T allele was found to be 
located within the core consensus sequence for the PPARƠ and 
its activators were proposed to have the ability to inhibit IL-2, 
IL-6, IL-18, and the tumor necrosis factor gene TNF [20] which 
is responsible for the shifting of T cells towards type 2 helper  T 
cells. This theory is not consistent with the À ndings of a study 
in which IL-4 levels were measured in human CD4+ T cells 
upon activation with a PPARƠ activator [21]; the drawback of 
that study, however, was that the authors were not sure about 
the allele they referred to as G2979T at the 3017 position. 
The C-33T SNP has been found to be strongly associated 
with asthma in the Russian population, with a highly signiÀ cant 
P value of <.001. The results of the current study for C-33T are 
similar to those of a recent study in the Chinese population [22]. 
In another study, Gervaziev et al [23] postulated that the 
locus containing C-33T (referred as T-33C) is part of the 
cAMP responsive element binding protein (CREB)-binding 
site; CREB is a regulatory protein involved in the activation 
of gene transcription in the cAMP-dependent pathway, and 
it is therefore possible that C-33T might be involved in the 
regulation of IL-4 expression through the modiÀ cation of the 
CREB-binding site [23]. 
Comparing current and previous studies, we can conclude 
that it might be interesting to analyze a block of SNPs (i.e. a 
Table 4. Allele Frequencies of IL-4 Polymorphisms in Controls and in Patients With Asthma and Allergic Rhinitis (AR)a
  
 Alleles Controls Asthma P Value OR AR P Value OR
   Patients (r2) (95% CI) Patients (r2) (95% CI)
rs2243250
      C  146 (60.8) 115 (53.2) .10 (2.68) 1.36 (0.92-2.01)
 98 (46.2) 
.001 (9.67)
 
1.81 (1.22-2.67)
      T  94 (39.2) 101 (46.8)   114 (53.8)
  
rs2227284
      T  184 (76.7) 130 (60.2) 
<.001 (14.40) 2.17 (1.42-3.33)
 92 (43.3) 
<.001 (52.41) 4.29 (2.81-6.56)
      G  56 (23.3) 86 (39.8)   120 (56.6)
  
rs2070874
      C  213 (88.75) 185 (85.6) 
.32 (0.99) 1.32 (0.74-2.38)
 198 (93.4) 
0.08 (2.95) 0.56 (0.27-1.14)
      T  27 (11.25) 31 (14.4)   14 (6.60)  
Abbreviations: IL-4, interleukin 4; OR, odds ratio.
aData are presented as number (%) unless otherwise indicated.
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haplotype) within a gene rather than studying single SNPs. We 
were not able to perform haplotype analysis, because we did 
not have sufÀ cient DNA for certain individuals. We therefore 
recommend the performance of further studies in the same 
patients and controls to help understand the combined effect 
of different SNPs in a gene. 
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